Company / EPS (Diluted)
CorVel Corporation EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$1.26
FY2025
5-year range
$1.26 / $3.66
FY2021-FY2025
Trend
-65.6%
vs FY2024
Sector context
#70 of 159
Health Care
What the data says
At $1.26, CorVel Corporation's eps (diluted) ranks #70 of 159 in the Health Care sector. Declined from $2.55 to $1.26 over the past 2 years.
Based on SEC 10-K filings.
1.26 in FY2025 with a 5-year CAGR of -7.6%.
Declined from $2.55 to $1.26 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -20.9%
- 5-Year CAGR
- -7.6%
- 10-Year CAGR
- -
Sector benchmark
#70 of 159 in Health CareTop 44% of 159This company $1.26 Sector average $1.64
▼
-23.1% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 65.6% year-over-year.
- Ranks #70 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.26 | -65.6% |
| FY2024 | $3.66 | +43.5% |
| FY2023 | $2.55 | +0.0% |
| FY2022 | $2.55 | +3.7% |
| FY2021 | $2.46 | +31.6% |
| FY2020 | $1.87 | +23.8% |
| FY2019 | $1.51 | +5.6% |
| FY2018 | $1.43 | +4.4% |
| FY2017 | $1.37 | -14.9% |
| FY2016 | $1.61 | +35.3% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026